Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

Finasteride increases CD8+ T cells in BPH tissues.

New compounds may help treat prostate issues without affecting androgen receptors.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Persistent ED in Propecia users is not due to abnormal blood flow.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

The new compound may be a safer alternative to finasteride for prostate protection.

Certain drugs that block specific enzymes can help treat prostate diseases.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.